Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    IRLAB Therapeutics

    MCap

    SEK653m

    Last close

    SEK14.10

    ▲ 1.50 (11.90%)

    VolitionRx

    MCap

    USD51m

    Last close

    USD0.60

    ▲ 0.05 (9.82%)

    Portobello SpA

    MCap

    EUR12m

    Last close

    EUR2.38

    ▲ 0.20 (9.17%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Treatt (LSE: TET)

Last close As at 04/11/2024

420.00

▲ 2.00 (0.48%)

Market capitalisation

257m

Treatt provides innovative ingredient solutions from its manufacturing bases in Europe, North America and Africa, principally for the flavours and fragrance industries, and multinational consumer goods companies with particular emphasis on the beverage sector.

Latest Insights

View More

Consumer | Update

Treatt — Return to growth in FY23

Consumer | Update

Treatt — FY23 profits in line despite headwinds

Consumer | Update

Treatt — A strong start to the year

Consumer | Update

Treatt — Strong revenue growth, profit in line
Treatt_resized
Visit Website

Sector

Consumer

Balance Sheet

Forecast net debt (£m)

5.4

Forecast gearing ratio (%)

4

Share Price Performance

Price Performance
% 1M 3M 12M
Actual (4.6) (14.8) (34.5)
Relative (6.2) (15.0) (36.9)
52 week high/low 724.0p/411.0p

Financials

Edison Investment Research is terminating coverage on Kinarus Therapeutics (KNRS), Numis Corporation (NUM), EMIS Group (EMIS), Pixium Vision (PIX) and Treatt (TET). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
Previously published reports can still be accessed via website

Y/E Sep Revenue (£m) EBITDA (£m) PBT (£m) EPS (fd) (p) P/E (x) P/CF (x)
2022A 140.2 19.5 16.5 25.4 16.5 N/A
2023A 147.4 24.2 19.0 22.9 18.3 10.8
2024E
2025E

Research

Treatt_resized

Update

Consumer

Treatt — FY23 profits in line despite headwinds

Update

Consumer

Treatt — A strong start to the year
Treatt_resized

Consumer

Update

Treatt — Return to growth in FY23

Treatt_resized

Update

Consumer

Treatt — Strong revenue growth, profit in line
Treatt_resized

Update

Consumer

Treatt — Back to steady growth

Update

Consumer

Treatt — Rebuilding confidence

Update

Treatt — Holding steady

Update

Consumer

Treatt — Rebasing expectations

Outlook

Consumer

Treatt — New facility to drive growth

Update

Consumer

Treatt — Upgrading revenue forecasts

Update

Consumer

Treatt — Reverting to a normal split
View All

Further insights

insight

Consumer

Natural Flavourings

Thematics

thematic

Consumer

ConsumerWatch – Don’t look down

thematic

Consumer

ConsumerWatch – The times they are a-changin’

thematic

Consumer

ConsumerWatch – Give me a reason to love you

thematic

Consumer

ConsumerWatch – At least someone loves me
View All

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free